401 related articles for article (PubMed ID: 26556739)
1. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p.
Kang H; Chen H; Huang P; Qi J; Qian N; Deng L; Guo L
Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling.
Shi C; Huang P; Kang H; Hu B; Qi J; Jiang M; Zhou H; Guo L; Deng L
J Mol Endocrinol; 2015 Jun; 54(3):325-37. PubMed ID: 25878056
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effect of microRNA-34a on osteogenesis and angiogenesis in glucocorticoid-induced osteonecrosis of the femoral head.
Zha X; Sun B; Zhang R; Li C; Yan Z; Chen J
J Orthop Res; 2018 Jan; 36(1):417-424. PubMed ID: 28543623
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor-α Inhibits Bone Marrow Stem Cell Differentiation into Osteoblasts by Downregulating microRNA-34a Expression.
Xin W; Wang X; Zhang W; Zhu H; Dong R; Zhang J
Ann Clin Lab Sci; 2019 May; 49(3):324-329. PubMed ID: 31308031
[TBL] [Abstract][Full Text] [Related]
5. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles derived from T-cell acute lymphoblastic leukemia inhibit osteogenic differentiation of bone marrow mesenchymal stem cells via miR-34a-5p.
Yuan T; Shi C; Xu W; Yang HL; Xia B; Tian C
Endocr J; 2021 Oct; 68(10):1197-1208. PubMed ID: 34039781
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate.
Lin Z; He H; Wang M; Liang J
Cell Prolif; 2019 Nov; 52(6):e12688. PubMed ID: 31557368
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells.
Chen L; Holmstrøm K; Qiu W; Ditzel N; Shi K; Hokland L; Kassem M
Stem Cells; 2014 Apr; 32(4):902-12. PubMed ID: 24307639
[TBL] [Abstract][Full Text] [Related]
9. microRNA-199a counteracts glucocorticoid inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro.
Tang J; Yu H; Wang Y; Duan G; Wang B; Li W; Zhu Z
Cell Biol Int; 2020 Dec; 44(12):2532-2540. PubMed ID: 32869899
[TBL] [Abstract][Full Text] [Related]
10. miR-34a promotes bone regeneration in irradiated bone defects by enhancing osteoblastic differentiation of mesenchymal stromal cells in rats.
Liu H; Dong Y; Feng X; Li L; Jiao Y; Bai S; Feng Z; Yu H; Li X; Zhao Y
Stem Cell Res Ther; 2019 Jun; 10(1):180. PubMed ID: 31215466
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway.
Xing Q; Feng J; Zhang X
Exp Cell Res; 2021 Jun; 403(1):112595. PubMed ID: 33838126
[TBL] [Abstract][Full Text] [Related]
12. miR-34a-5p facilitates osteogenic differentiation of bone marrow mesenchymal stem cells and modulates bone metabolism by targeting HDAC1 and promoting ER-α transcription.
Sun D; Chen Y; Liu X; Huang G; Cheng G; Yu C; Fang J
Connect Tissue Res; 2023 Mar; 64(2):126-138. PubMed ID: 36537660
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment.
Chen TL
Bone; 2004 Jul; 35(1):83-95. PubMed ID: 15207744
[TBL] [Abstract][Full Text] [Related]
14. Plastrum Testudinis Extracts Promote BMSC Proliferation and Osteogenic Differentiation by Regulating Let-7f-5p and the TNFR2/PI3K/AKT Signaling Pathway.
Shen GY; Ren H; Huang JJ; Zhang ZD; Zhao WH; Yu X; Shang Q; Qiu T; Zhang YZ; Tang JJ; Liang D; Yang ZD; Jiang XB
Cell Physiol Biochem; 2018; 47(6):2307-2318. PubMed ID: 29975930
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.
Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G
Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625
[TBL] [Abstract][Full Text] [Related]
16. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
[TBL] [Abstract][Full Text] [Related]
17. Effect of miR-26a-5p on the Wnt/Ca(2+) Pathway and Osteogenic Differentiation of Mouse Adipose-Derived Mesenchymal Stem Cells.
Li S; Hu C; Li J; Liu L; Jing W; Tang W; Tian W; Long J
Calcif Tissue Int; 2016 Aug; 99(2):174-86. PubMed ID: 27040676
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MIAT can regulate the proliferation, apoptosis, and osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting miR-150-5p.
Wang F; Deng H; Chen J; Wang Z; Yin R
Bioengineered; 2022 Mar; 13(3):6343-6352. PubMed ID: 35282774
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
Ma X; Zhang X; Jia Y; Zu S; Han S; Xiao D; Sun H; Wang Y
Int Orthop; 2013 Jul; 37(7):1399-404. PubMed ID: 23645083
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles Targeting Delivery Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Treat Osteoporosis by Increasing Bone Formation.
Zhou Y; Jia H; Hu A; Liu R; Zeng X; Wang H
Curr Stem Cell Res Ther; 2023; 18(1):115-126. PubMed ID: 35473519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
